(Q22306058)

30 March 2023

Bruce C. Marshall

2

Bruce C

Marshall

1 reference

30 March 2023

Beth Sufian

3

Beth

Sufian

1 reference

30 March 2023

Richard H. Simon

4

Richard H

Simon

1 reference

30 March 2023

David Rodman

5

David

Rodman

1 reference

Demineralization in cystic fibrosis detected by direct photon absorptiometry

30 March 2023

language of work or name

English

0 references

publication date

January 2004

0 references

1 reference

125

0 references

issue

1

0 references

page(s)

1S-39S

0 references

cites work

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Heart failure in cystic fibrosis. Treatment and prognosis of cor pulmonale with failure of the right side of the heart

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Evaluation of pulmonary hypertrophic osteoarthropathy in cystic fibrosis. A comprehensive study

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Assisted Ventilation for Patients With Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Detection of prostate and colon cancer

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Proportion of cystic fibrosis gene mutations not detected by routine testing in men with obstructive azoospermia

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Perspectives on care at the close of life. Management of dyspnea in patients with far-advanced lung disease: "once I lose it, it's kind of hard to catch it... "

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Survival effect of lung transplantation among patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Transition to adult health care for adolescents and young adults with cancer

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Scintigraphic documentation of an improvement in hepatobiliary excretory function after treatment with ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response study.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Clinical pharmacology of pancreatic enzymes in patients with cystic fibrosis and in vitro performance of microencapsulated formulations

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

The diagnosis of osteoporosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Effects of salmeterol on arterial oxyhemoglobin saturations in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Effectiveness and tolerability of high-dose salmeterol in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Transmission of colistin-resistant Pseudomonas aeruginosa between patients attending a pediatric cystic fibrosis center.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Long-term tobramycin aerosol therapy in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Long-term effects of inhaled tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Cystic Fibrosis Foundation consensus conference report on pulmonary complications of cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Short-term and long-term effects of albuterol aerosol therapy in cystic fibrosis: a preliminary report

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

CFTR deltaF508 carrier status, risk of breast cancer before the age of 40 and histological grading in a population-based case-control study

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Airway responsiveness to hyperosmolar saline challenge in cystic fibrosis: A pilot study

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

A placebo-controlled, double-blind trial of the long-term effects of albuterol administration in patients with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Effects of standard and high doses of salmeterol on lung function of hospitalized patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Evaluation of fecal pancreatic elastase-1 as a measure of pancreatic exocrine function in children with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Bone changes associated with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

A double-blind placebo controlled trial with oral ambroxol and N-acetylcysteine for mucolytic treatment in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Critical examination of therapeutic efficacy of a pH-sensitive enteric-coated pancreatic enzyme preparation in treatment of exocrine pancreatic insufficiency secondary to cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Crohn's disease and cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Altered calcium homeostasis in adults with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Lipid levels in adults with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Cystic fibrosis in adults. 75 cases and a review of 232 cases in the literature

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Clinical features, survival rate, and prognostic factors in young adults with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Osteopenia in adults with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Cervical mucus in cystic fibrosis: A possible cause of infertility

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

A controlled trial of nebulized aminoglycoside and oral flucloxacillin versus placebo in the outpatient management of children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Hepatoprotective properties of ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

The spectrum of appendiceal disease in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Meta-analysis of value of propranolol in prevention of variceal haemorrhage

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Mild cystic fibrosis and normal or borderline sweat test in patients with the 3849 + 10 kb C-->T mutation

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

The effects of the inhaled corticosteroid budesonide on lung function and bronchial hyperresponsiveness in adult patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Transition program from pediatric to adult care for Cystic Fibrosis patients

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Transition from child-centered to adult health-care systems for adolescents with chronic conditions. A position paper of the Society for Adolescent Medicine

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Transition to adult health care: Setting the stage

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Osteoporosis in lung transplantation candidates with end-stage pulmonary disease

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Water and electrolytes in cervical mucus from patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Microsurgical epididymal sperm aspiration and intracytoplasmic sperm injection: a new effective approach to infertility as a result of congenital bilateral absence of the vas deferens.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Acute bronchodilator response to a combination of beta-adrenergic and anticholinergic agents in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Effects of ursodeoxycholic acid on liver function in patients with cystic fibrosis and chronic cholestasis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Effects of cisapride in patients with cystic fibrosis and distal intestinal obstruction syndrome

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Oral administration of n-acetyl cysteine in the prophylaxis of “meconium ileus equivalent”

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Fecal chymotrypsin: A reliable index of exocrine pancreatic function in children

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Reduced serum 25-hydroxyvitamin D concentration and disordered mineral metabolism in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Immediate and long-term effects of chest physiotherapy in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Osteoporosis in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Diabetes mellitus associated with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Role of conventional physiotherapy in cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Nocturnal home oxygen in the treatment of hypoxemic cystic fibrosis patients.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Kyphosis and fractures in children and young adults with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Improvement of nutritional status and lung function after long-term nocturnal gastrostomy feedings in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Analysis of risk factors for the development of liver disease associated with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Clinical denouement and mutation analysis of patients with cystic fibrosis undergoing liver transplantation for biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Cystic fibrosis-associated colitis and fibrosing colonopathy

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. Consensus Committee

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Pilot study to assess the effect of inhaled corticosteroids on lung function in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Bone density in children and adolescents with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Long-term comparative trial of conventional postural drainage and percussion versus positive expiratory pressure physiotherapy in the treatment of cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Ursodeoxycholic acid improves the hepatic metabolism of essential fatty acids and retinol in children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Abnormal glucose metabolism in cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Uncertainty in the diagnosis of cystic fibrosis: possible role of in vivo nasal potential difference measurements

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Enteral nutrition for patients with cystic fibrosis: comparison of a semi-elemental and nonelemental formula

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Results in the United States with sperm microaspiration retrieval techniques and assisted reproductive technologies. The Sperm Microaspiration Retrieval Techniques Study Group

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Cystic fibrosis mutations and genetic predisposition to idiopathic chronic pancreatitis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Life beyond pediatrics. Transition of chronically ill adolescents from pediatric to adult health care systems

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Living donor lung transplantation: selection, technique, and outcome

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Ursodeoxycholic acid for primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Long-term azithromycin may improve lung function in children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Cystic fibrosis and pregnancy. A national survey

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Effect of swimming on forced expiration and sputum clearance in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Coeliac disease and malignancy

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Inhaled antibiotics in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Nebulised colomycin for early pseudomonas colonisation in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Treatment of distal intestinal obstruction syndrome in cystic fibrosis with a balanced intestinal lavage solution

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Liver disease and bile duct abnormalities in adults with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Fibrosing colonopathy in cystic fibrosis: results of a case-control study

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Outcome of cystic fibrosis-associated liver cirrhosis: management of portal hypertension

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Nutrition in adults with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Basic therapies in cystic fibrosis. Does standard therapy work?

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

N-acetylcysteine by metered dose inhaler in the treatment of chronic bronchitis: a multi-centre study

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

A cohort study of cystic fibrosis and malignancy

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Cystic fibrosis hetero- and homozygosity is associated with inhibition of breast cancer growth

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Primary prophylaxis of variceal bleeding in cirrhosis: a cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Liver disease and common-bile-duct stenosis in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Cystic fibrosis gene mutation in two sisters with mild disease and normal sweat electrolyte levels

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Prediction of Mortality in Patients with Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

The prognostic value of exercise testing in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

A Novel Mutation in the Cystic Fibrosis Gene in Patients with Pulmonary Disease but Normal Sweat Chloride Concentrations

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

The Risk of Cancer among Patients with Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Effect of high-dose ibuprofen in patients with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Management of pulmonary disease in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Mutations of the cystic fibrosis gene in patients with chronic pancreatitis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

A randomized controlled trial of a 3-year home exercise program in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Treatment of vitamin K deficiency in cystic fibrosis: Effectiveness of a daily fat-soluble vitamin combination

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Long-term comparative trial of positive expiratory pressure versus oscillating positive expiratory pressure (flutter) physiotherapy in the treatment of cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

How useful is fecal pancreatic elastase 1 as a marker of exocrine pancreatic disease?

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Microbiology of sputum from patients at cystic fibrosis centers in the United States

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Nutritional assessment and management in cystic fibrosis: a consensus report. The Consensus Committee

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Predictive 5-year survivorship model of cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Antibiotic susceptibility of multiply resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis, including candidates for transplantation

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Isolation rate and toxigenic potential of Clostridium difficile isolates from patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Fecal occult blood screening in the Minnesota study: sensitivity of the screening test.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Determinants of mortality from cystic fibrosis in Canada, 1970-1989.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Gender gap in cystic fibrosis mortality

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Cystic fibrosis: gastrointestinal complications

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Relative effects of bronchial drainage and exercise for in-hospital care of patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Cystic fibrosis, chronic bacterial infection and rheumatic disease

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Long-term prospective study of the effect of ursodeoxycholic acid on cystic fibrosis-related liver disease

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Esophageal pH monitoring data during chest physiotherapy.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Nutritional Rehabilitation in Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Effect of a Medium Dose of Ursodeoxycholic Acid with or without Taurine Supplementation on the Nutritional Status of Patients with Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Effect of ursodeoxycholic acid therapy on hepatic function in children with intrahepatic cholestatic liver disease

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Recommendations for management of liver and biliary tract disease in cystic fibrosis. Cystic Fibrosis Foundation Hepatobiliary Disease Consensus Group

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

The interaction of 2 diseases: diabetes mellitus and cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Gastrointestinal, liver, and pancreatic involvement in adult patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Lung transplantation for cystic fibrosis: an update and practical considerations for referring candidates

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

First adult patient with fibrosing colonopathy

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Relative underweight in cystic fibrosis and its prognostic value

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis. A longitudinal study of immune complex activity and inflammatory response in sputum sol-phase of cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infections: influenc

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Long-term effects of physical exercise on working capacity and pulmonary function in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Failure of ursodeoxycholic acid to dissolve radiolucent gallstones in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Arthritis in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Gastrografin in acute meconium ileus equivalent

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Appendicitis in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Interleukin-1 alpha, soluble interleukin-2 receptor, and IgG concentrations in cystic fibrosis treated with prednisolone

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Liver transplantation for hepatic cirrhosis in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Bronchoconstriction following nebulised colistin in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Percutaneous endoscopic gastrostomy feeding in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Asymptomatic carriage of Clostridium difficile in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Elective versus symptomatic antibiotic treatment in cystic fibrosis patients with chronic Pseudomonas infection of the lungs

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Effect of intravenous pamidronate on bone mineral density in adults with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Prednisolone in the treatment of airflow obstruction in adults with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Vitamin D and parathyroid hormone and bone mineralisation in adults with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Effect of chest physiotherapy on oxygen saturation in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Cystic fibrosis: current survival and population estimates to the year 2000.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Treatment compliance in adults with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Genetic and clinical features of patients with cystic fibrosis diagnosed after the age of 16 years

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Low bone mineral density in adults with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Hepatobiliary and pancreatic manifestations of cystic fibrosis: MR imaging appearances

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Colonic carcinoma in two adult cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Colonic disorders in adult cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Predictive Value of Oropharyngeal Cultures for Identifying Lower Airway Bacteria in Cystic Fibrosis Patients

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Review of the clinical efficacy of theophylline in the treatment of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Comparison of high frequency chest compression and conventional chest physiotherapy in hospitalized patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Cystic fibrosis 3849+10kb C > T mutation associated with severe pulmonary disease and male fertility

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Aerosolized recombinant human DNase in hospitalized cystic fibrosis patients with acute pulmonary exacerbations

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

The effects of albuterol on the lung function of hospitalized patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

1 reference

7 January 2021

Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease I.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Bone mass and vitamin D deficiency in adults with advanced cystic fibrosis lung disease

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

International guidelines for the selection of lung transplant candidates. The American Society for Transplant Physicians (ASTP)/American Thoracic Society(ATS)/European Respiratory Society(ERS)/International Society for Heart and Lung Transplantation

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

1 reference

7 January 2021

Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Bone density, body composition, and inflammatory status in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Low-flow oxygen and bilevel ventilatory support: effects on ventilation during sleep in cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Outcomes of intensive care unit care in adults with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Oxygen saturation during exercise in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Bronchodilators increase airway instability in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Sodium chloride increases the ciliary transportability of cystic fibrosis and bronchiectasis sputum on the mucus-depleted bovine trachea

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Prolonged parenteral nutrition for cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

The effects of recombinant human DNase on neutrophil elastase activity and interleukin-8 levels in the sputum of patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Nocturnal ventilatory support in patients with cystic fibrosis: comparison with supplemental oxygen

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Bone demineralization in cystic fibrosis: evidence of imbalance between bone formation and degradation.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Assessment of Readiness to Transfer to Adult Care for Adolescents with Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Severe osteoporosis before and after lung transplantation

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Effects of 12-week administration of dornase alfa in patients with advanced cystic fibrosis lung disease. Pulmozyme Study Group

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Lung transplantation in cystic fibrosis: consensus conference statement

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Risk of death in cystic fibrosis patients with severely compromised lung function.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Timing of referral for lung transplantation for cystic fibrosis: overemphasis on FEV1 may adversely affect overall survival

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Pulmonary hypertension and cardiac function in adult cystic fibrosis: role of hypoxemia.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Hypoxemia and hypercapnia during exercise and sleep in patients with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Health status and sociodemographic characteristics of adults receiving a cystic fibrosis diagnosis after age 18 years

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Fertility in Men With Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Predictability of oxygen desaturation during sleep in patients with cystic fibrosis : clinical, spirometric, and exercise parameters.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Ventilation and oxygenation changes during sleep in cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Use of oral contraceptives in women with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

The inhaled bronchodilators ipratropium bromide and metaproterenol in adults with CF

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Nebulized ipratropium in the treatment of acute asthma

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

A controlled trial of long-term bronchodilator therapy in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

End-of-life care in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Transjugular intrahepatic portosystemic shunt in a child with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Atypical presentation of Clostridium difficile colitis in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Low-dose versus high-dose ursodeoxycholic acid in cystic fibrosis-related cholestatic liver disease. Results of a randomized study with 1-year follow-up

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Screening for osteoporosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Omeprazole enhances the efficacy of pancreatin (pancrease) in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021

Pregnancy in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1378%2FCHEST.125.1_SUPPL.1S

7 January 2021